Intranasal administration of acetylcholinesterase inhibitors

This short review outlines the rationale, challenges, and opportunities for intranasal acetylcholinesterases, in particular galantamine. An in vitro screening model facilitated the development of a therapeutically viable formulation. In vivo testing confirmed achievement of therapeutically relevant...

Descripción completa

Detalles Bibliográficos
Autores principales: Costantino, Henry R, Leonard, Alexis Kays, Brandt, Gordon, Johnson, Paul H, Quay, Steven C
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604884/
https://www.ncbi.nlm.nih.gov/pubmed/19091003
http://dx.doi.org/10.1186/1471-2202-9-S3-S6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604884/
https://www.ncbi.nlm.nih.gov/pubmed/19091003
http://dx.doi.org/10.1186/1471-2202-9-S3-S6

Ejemplares similares